THYMOSIN A1 Deus Medical
| Features | |
| Active substance | Thymosin Alpha-1 |
| Also known as | TA1, Thymalfasin |
| Blood pressure | No significant impact |
| Chemical name | L-serine, L-tyrosyl-L-glutaminyl-L-cysteinyl-L-glutaminyl-L-threonyl-L-seryl-L-cysteinyl-L-prolyl-L-seryl-L-lysyl-L-leucyl-L-glutaminyl-L-threonyl-L-leucyl-L-glutamyl-L-asparaginyl-L-lysyl-L-lysyl-L-arginyl-L-arginyl-L-lysyl-L-threonyl-L-lysyl-L-leucyl-L-lysyl-L-glutamyl-L-threonyl-L-asparaginyl-L-threonyl-L-argininamide |
| Dosage (medical) | Typically 1.6 mg daily |
| Dosage (sports) | Not officially sanctioned for sports use |
| Effects | Enhanced immune response, increased activity of T-cells, modulation of cytokine production |
| FORM | 1 vial x 10 mg |
| Formula | C129H215N33O55 |
| Half-life | Approximately 2 minutes |
| Hepatotoxicity | Minimal to none |
| Lab Test | Immune response markers and T-cell counts |
| Main action | Immune modulation |
| Side effects | Local reactions at the injection site, possible systemic reactions like fever or fatigue |
| Storage conditions | Store in a refrigerator at 2-8В°C |
| Substance class | Peptide hormone |
| Trade name | Zadaxin |
| Use in sports | Not approved, potential use for immune support |
| Water Retention | None |
| Manufacturer | DEUS MEDICAL |